First, we've got cilomilast, which I've never even heard of in this context. Alcon are licensing it from GlaxoSmithKline for ophthalmic indications.
Then, we've got a closer relationship with Origenis:
Alcon expanded its existing drug research alliance with Origenis with a focus on the discovery and development of the small molecules that might one day have a role in the treatment of eye diseases.
Here's the whole article if you're interested:
Alcon Pads Eye-Disease Pipeline through Deals with GSK and Origenis
2 comments:
An example of where Alcon IS spending big dollars in the dry eye world is with one of the best artificial tears on the market - Systane Ultra.
Daniel Tepper, MD
Lotus Eyecare, PC
www.lotuseyecare.com
Systane is just another artificial tear. Its a good one but for those with moderate/severe dry eye we need more. They should start developing something that will actually do more than just alleviate symptoms for a minute. Glad to see they are keeping with the times now.
Post a Comment